Irradiated homologous rib grafts in nasal reconstruction.
OBJECTIVE
To assess the long-term efficacy of irradiated homologous rib grafts (IHRGs) for both augmentation and support function in rhinoplasty in general and for specific recipient sites within the nose.


METHODS
A retrospective study was conducted at an academic medical center to evaluate the loss of volume and support function of IHRGs in 9 specific recipient sites in the nose.


RESULTS
We studied 66 patients, with a total of 177 IHRGs, dating back 9 years, with an average follow-up of 51 months. The rate of resorption increased with duration of follow-up. Complete resorption was found in 1 IHRG, and moderate resorption was observed in 55 IHRGs (31%). Resorption was characterized by a loss of support function rather than a loss of volume. Moderate resorption had a negative clinical outcome for shield grafts only.


CONCLUSIONS
Irradiated homologous rib grafts were safe to use in rhinoplasty. In cases requiring a shield graft, IHRGs should be avoided.
Department of Otorhinolaryngology-Head and Neck Surgery, Center for Facial Plastic and Reconstructive Surgery, Academic Medical Center, University of Amsterdam, Meibergdreef 9, Amsterdam, the Netherlands. d.j.menger@amc.uva.nl
Dirk J
DJ
Menger
Gilbert J
GJ
Nolst Trenité
D000293:Adolescent; D000328:Adult; D000368:Aged; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D012225:Rhinoplasty / Q000379:methods*; D012272:Ribs / Q000528:radiation effects*; D014184:Transplantation, Homologous; D055815:Young Adult